A vaccine for one of the most lethal cancers, advanced melanoma, has improved response rate and progression-free survival for patients when combined with the immunotherapy drug Interleukin-2, according to new research.

Source: Therapeutic melanoma vaccine improves response rate, progression-free survival, study finds


David Cottle

UBB Owner & Administrator